MiMedx Group, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was 84.56K shares, a 213.19% increase year-over-year.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-09-30 was 58.27K shares, a 15.00% increase year-over-year.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-06-30 was 4.33K shares, a 96.06% decline year-over-year.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 207.69K shares, a 41.13% increase from fiscal 2023.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 147.16K shares, a 52.83% decline from fiscal 2022.
- MiMedx Group, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 312.00K shares, a 41.04% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-25 | |
| 2024-12-31 | 207.69K shares 10-K · filed 2025-02-26 | |
| 2023-12-31 | 84.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 147.16K shares 10-K · filed 2024-02-28 |
| 2023-09-30 | 58.27K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | 89.60K shares derived: sum of 4 quarters · filed 2023-10-30 |
| 2023-06-30 | 4.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | 82.00K shares derived: sum of 4 quarters · filed 2023-08-01 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-02 | 187.67K shares derived: sum of 4 quarters · filed 2023-05-02 |
| 2022-12-31 | 27.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 312.00K shares 10-K · filed 2023-02-28 |
| 2022-09-30 | 50.67K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | 290.00K shares derived: sum of 4 quarters · filed 2022-11-02 |
| 2022-06-30 | 110.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | 269.37K shares derived: sum of 4 quarters · filed 2022-08-02 |
| 2022-03-31 | 124.33K shares 10-Q · filed 2022-05-03 | 300.88K shares derived: sum of 4 quarters · filed 2022-05-03 |
| 2021-12-31 | 5.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 529.17K shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 30.03K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | |
| 2021-06-30 | 141.52K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | |
| 2021-03-31 | 352.62K shares 10-Q · filed 2021-04-28 | |
| 2020-12-31 | 508.30K shares 10-K · filed 2021-03-08 | |
| 2019-12-31 | 150.00K shares 10-K · filed 2020-07-06 | |
| 2018-12-31 | 786.71K shares 10-K · filed 2020-03-17 | |
| 2017-09-30 | 460.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | 2.66M shares derived: sum of 4 quarters · filed 2017-10-31 |
| 2017-06-30 | 1.57M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | 2.32M shares derived: sum of 4 quarters · filed 2017-07-31 |
| 2017-03-31 | 387.65K shares 10-Q · filed 2017-05-01 | 943.07K shares derived: sum of 4 quarters · filed 2017-05-01 |
| 2016-12-31 | 238.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | 1.16M shares 10-K · filed 2017-03-01 |
| 2016-09-30 | 121.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | 1.40M shares derived: sum of 4 quarters · filed 2017-02-22 |
| 2016-06-30 | 195.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | 1.66M shares derived: sum of 4 quarters · filed 2017-02-22 |
| 2016-03-31 | 608.72K shares 10-Q · filed 2016-05-10 | 2.07M shares derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-12-31 | 475.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | 2.22M shares 10-K · filed 2017-02-22 |
| 2015-09-30 | 382.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | 2.25M shares derived: sum of 4 quarters · filed 2015-11-06 |
| 2015-06-30 | 603.44K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | 2.40M shares derived: sum of 4 quarters · filed 2015-08-07 |
| 2015-03-31 | 760.16K shares 10-Q · filed 2015-05-01 | 2.10M shares derived: sum of 4 quarters · filed 2015-05-01 |
| 2014-12-31 | 506.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | 1.65M shares 10-K · filed 2015-03-13 |
| 2014-09-30 | 533.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | 1.50M shares derived: sum of 4 quarters · filed 2014-11-10 |
| 2014-06-30 | 296.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | 2.08M shares derived: sum of 4 quarters · filed 2014-08-11 |
| 2014-03-31 | 317.19K shares 10-Q · filed 2014-05-12 | 2.11M shares derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | 348.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | 1.96M shares 10-K · filed 2014-03-04 |
| 2013-09-30 | 1.12M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | |
| 2013-06-30 | 319.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | |
| 2013-03-31 | 170.10K shares 10-Q · filed 2013-05-10 | |
| 2012-12-31 | 843.86K shares 10-K · filed 2013-03-15 | |
| 2011-12-31 | 490.00K shares 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |